Downregulation of EGFR in a metastatic brain lesion of EGFR-mutated non-small cell lung cancer using a tyrosine kinase inhibitor: A case report

Documenti analoghi

• BMET-22 DIFFERENT SPATIAL DISTRIBUTION OF BRAIN METASTASIS FROM LUNG CANCER DEFINED BY EGFR MUTATION STATUS
  di: Takano, Koji, et al.
  Pubblicazione: (2015)
• Pleural sarcoidosis diagnosed on the basis of an increased CD4/CD8 lymphocyte ratio in pleural effusion fluid: a case report
  di: Kumagai, Toru, et al.
  Pubblicazione: (2015)
• Different spatial distributions of brain metastases from lung cancer by histological subtype and mutation status of epidermal growth factor receptor
  di: Takano, Koji, et al.
  Pubblicazione: (2016)
• A long-term survivor of non-small-cell lung cancer harboring concomitant EGFR mutation and ALK translocation
  di: Imamura, Fumio, et al.
  Pubblicazione: (2016)
• Early responses of EGFR circulating tumor DNA to EGFR tyrosine kinase inhibitors in lung cancer treatment
  di: Imamura, Fumio, et al.
  Pubblicazione: (2016)